The population risk attribution associated with chronic airway obstruction from the results of the Canadian Obstructive Lung Disease study.

W. Tan (Vancouver, Canada), P. Li (Montreal, Canada), R. Choi (Vancouver, Canada), J. Bourbeau (Montreal, Canada), S. Aaron (Ottawa, Canada), C. Leung (Vancouver, Canada), F. Maltais (Quebec city, Canada), P. Hernandez (Halifax, Canada), K. Chapman (Toronto, Canada), B. Walker (Calgary, Canada), D. Marciniuk (Saskatoon, Canada), D. O'Donnell (Kingston, Canada), J. Hogg (Vancouver, Canada), J. Road (Vancouver, Canada), M. Fitzgerald (Vancouver, Canada), A. Amaral (London, United Kingdom), W. Vollmer (Portland, United States of America), P. Burney (London, United Kingdom), S. Buist (Portland, United States of America), D. Sin (Vancouver, Canada)

Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Session: COPD burden, epidemiology and management
Session type: E-poster
Number: 3506

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Tan (Vancouver, Canada), P. Li (Montreal, Canada), R. Choi (Vancouver, Canada), J. Bourbeau (Montreal, Canada), S. Aaron (Ottawa, Canada), C. Leung (Vancouver, Canada), F. Maltais (Quebec city, Canada), P. Hernandez (Halifax, Canada), K. Chapman (Toronto, Canada), B. Walker (Calgary, Canada), D. Marciniuk (Saskatoon, Canada), D. O'Donnell (Kingston, Canada), J. Hogg (Vancouver, Canada), J. Road (Vancouver, Canada), M. Fitzgerald (Vancouver, Canada), A. Amaral (London, United Kingdom), W. Vollmer (Portland, United States of America), P. Burney (London, United Kingdom), S. Buist (Portland, United States of America), D. Sin (Vancouver, Canada). The population risk attribution associated with chronic airway obstruction from the results of the Canadian Obstructive Lung Disease study.. 3506

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Poverty and chronic airflow obstruction in the multinational Burden of Obstructive Lung Disease (BOLD) study: An update
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


The European Respiratory Society spirometry tent: a unique form of screening for airway obstruction
Source: Eur Respir J 2012; 39: 1458-1467
Year: 2012



Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study
Source: Eur Respir J 2013; 41: 548-555
Year: 2013



Overlap of OSA and Obstructive Airways Disease in Indian population: Does treating the underlying airflow obstruction improve OSA control?
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


Unemployment in chronic airflow obstruction (CAO) around the world: Results from the Burden of Obstructive Lung Disease (BOLD) study
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD)
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


Chronic Obstructive Pulmonary Disease (COPD) patients with airway eosinophilic inflammation are characterized by lower functional impairment.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Do GOLD stages of COPD severity really correspond to differences in health status?
Source: Eur Respir J 2003; 22: 444-449
Year: 2003



Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Home management of severe Chronic Obstructive Pulmonary Disease (COPD): results from a randomized controlled study in Italy
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019

Comparing the Comorbidity burden in Chronic Obstructive Pulmonary Disease and Heart Failure : evidence from a large population cohort
Source: International Congress 2019 – More and more COPD
Year: 2019

Obstructive sleep apnea accelerates decline in FEV1 in asthmatic patients
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014


Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002

Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


A weighted genetic risk score based on 279 signals of association with lung function predicts Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us?
Year: 2018




“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

COPD prevalence in Portugal. The Burden of Obstructive Lung Disease study (BOLD)
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010